Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Development of a Calculated Panel Reactive Antibody Web Service with Local Frequencies for Platelet Transfusion Refractoriness Risk Stratification.

Gordon WJ, Ainsworth L, Aronson S, Baronas J, Kaufman RM, Guleria I, Milford EL, Oates M, Paz RD, Yeung MY, Lane WJ.

J Pathol Inform. 2019 Aug 1;10:26. doi: 10.4103/jpi.jpi_29_19. eCollection 2019.

2.

First Report of Perfluorobutane Microsphere-Enhanced Ultrasound in the Transplant Kidney.

Siedlecki AM, Benson C, Frates M, Azzi J, Hoffman RJ, Milford E, Weins A, Chandraker A, Mc Donald N, Philip White J, Abdi R.

Transplantation. 2019 Oct;103(10):e283-e284. doi: 10.1097/TP.0000000000002856. No abstract available.

PMID:
31335773
3.

Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation.

Uffing A, Hidalgo LG, McMullan C, Perry J, Milford EL, Murakami N, Yeung MY, Guleria I, Wood IG, Akalin E, Azzi J, Chandraker AK, Riella LV.

Transplant Direct. 2019 Apr 15;5(5):e446. doi: 10.1097/TXD.0000000000000893. eCollection 2019 May.

4.

Resuscitation Fluid Choices to Preserve the Endothelial Glycocalyx.

Milford EM, Reade MC.

Crit Care. 2019 Mar 9;23(1):77. doi: 10.1186/s13054-019-2369-x. Review.

5.

Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.

Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P.

Am J Transplant. 2018 Jul;18(7):1604-1614. doi: 10.1111/ajt.14752. Epub 2018 May 22.

6.

Association of Cold Ischemia Time With Acute Renal Transplant Rejection.

Postalcioglu M, Kaze AD, Byun BC, Siedlecki A, Tullius SG, Milford EL, Paik JM, Abdi R.

Transplantation. 2018 Jul;102(7):1188-1194. doi: 10.1097/TP.0000000000002106.

7.

Detection and clinical impact of human leukocyte antigen antibodies in lung transplantation: A systematic review and meta-analysis.

Courtwright A, Diamond JM, Wood I, Guleria I, Milford E, El-Chemaly S, Goldberg HJ.

HLA. 2018 Feb;91(2):102-111. doi: 10.1111/tan.13185. Epub 2017 Dec 20.

PMID:
29178607
8.

A simple questionnaire to detect chronic kidney disease patients from Long An province screening data in Vietnam.

Tran HTB, Du TTN, Phung ND, Le NH, Nguyen TB, Phan HT, Vo T, Milford EL, Tran SN.

BMC Res Notes. 2017 Oct 30;10(1):523. doi: 10.1186/s13104-017-2847-7.

9.

The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death.

Zazueta OE, Preston SE, Moniodis A, Fried S, Kim M, Townsend K, Wood I, Boukedes S, Guleria I, Camp P, El-Chemaly S, Rosas IO, Chandraker A, Milford E, Goldberg HJ.

Transplantation. 2017 Sep;101(9):2207-2212. doi: 10.1097/TP.0000000000001494.

PMID:
27893614
10.

Face Transplantation in a Highly Sensitized Recipient.

Chandraker A, Arscott R, Murphy G, Lian C, Bueno E, Marty F, Rennke H, Milford E, Tullius S, Pomahac B.

Mil Med. 2016 Oct;181(10):1392. No abstract available.

PMID:
27753587
11.

Antibodies against HLA-DP recognize broadly expressed epitopes.

Simmons DP, Kafetzi ML, Wood I, Macaskill PC, Milford EL, Guleria I.

Hum Immunol. 2016 Dec;77(12):1128-1139. doi: 10.1016/j.humimm.2016.09.008. Epub 2016 Sep 21.

PMID:
27664843
12.

A Violaceous Nodule in a Lung-transplant Patient.

Milford E, Winslow C, Danhof R.

Dermatol Online J. 2016 Jun 15;22(6). pii: 13030/qt1d158857.

PMID:
27617611
13.

Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation.

Courtwright AM, Fried S, Villalba JA, Moniodis A, Guleria I, Wood I, Milford E, Mallidi HH, Hunninghake GM, Raby BA, Agarwal S, Camp PC, Rosas IO, Goldberg HJ, El-Chemaly S.

PLoS One. 2016 Sep 2;11(9):e0162409. doi: 10.1371/journal.pone.0162409. eCollection 2016.

14.

Activation of the protein C pathway and endothelial glycocalyx shedding is associated with coagulopathy in an ovine model of trauma and hemorrhage.

van Zyl N, Milford EM, Diab S, Dunster K, McGiffin P, Rayner SG, Staib A, Reade MC, Fraser JF.

J Trauma Acute Care Surg. 2016 Oct;81(4):674-84. doi: 10.1097/TA.0000000000001190.

PMID:
27488493
15.

Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling.

Gill RM, Mehra V, Milford E, Dhoot GK.

Histochem Cell Biol. 2016 Oct;146(4):431-44. doi: 10.1007/s00418-016-1454-3. Epub 2016 Jun 13.

PMID:
27294358
16.

Face Transplantation in a Highly Sensitized Recipient.

Chandraker A, Arscott R, Murphy G, Lian C, Bueno E, Marty F, Rennke H, Milford E, Tullius S, Pomahac B.

Mil Med. 2016 May;181(5 Suppl):221-6. doi: 10.7205/MILMED-D-15-00136. Erratum in: Mil Med. 2016 Oct;181(10 ):1392.

PMID:
27168576
17.

Evaluating Dermatology Residency Program Websites.

Ashack KA, Burton KA, Soh JM, Lanoue J, Boyd AH, Milford EE, Dunnick C, Dellavalle RP.

Dermatol Online J. 2016 Mar 16;22(3). pii: 13030/qt7rx3j2dn.

18.

Out of the classroom and into the community: medical students consolidate learning about health literacy through collaboration with Head Start.

Milford E, Morrison K, Teutsch C, Nelson BB, Herman A, King M, Beucke N.

BMC Med Educ. 2016 Apr 23;16:121. doi: 10.1186/s12909-016-0635-z.

19.

Comprehensive review of platelet storage methods for use in the treatment of active hemorrhage.

Milford EM, Reade MC.

Transfusion. 2016 Apr;56 Suppl 2:S140-8. doi: 10.1111/trf.13504. Review.

PMID:
27100750
20.

Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes.

Jindra PT, Conway SE, Ricklefs SM, Porcella SF, Anzick SL, Haagenson M, Wang T, Spellman S, Milford E, Kraft P, McDermott DH, Abdi R.

Biol Blood Marrow Transplant. 2016 Jan;22(1):27-36. doi: 10.1016/j.bbmt.2015.08.037. Epub 2015 Sep 5.

21.

Fatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3.

Goettel JA, Biswas S, Lexmond WS, Yeste A, Passerini L, Patel B, Yang S, Sun J, Ouahed J, Shouval DS, McCann KJ, Horwitz BH, Mathis D, Milford EL, Notarangelo LD, Roncarolo MG, Fiebiger E, Marasco WA, Bacchetta R, Quintana FJ, Pai SY, Klein C, Muise AM, Snapper SB.

Blood. 2015 Jun 18;125(25):3886-95. doi: 10.1182/blood-2014-12-618363. Epub 2015 Apr 1.

22.

Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation.

Diaz-Siso JR, Fischer S, Sisk GC, Bueno E, Kueckelhaus M, Talbot S, Carty MJ, Treister NS, Marty F, Milford EL, Pomahac B, Tullius SG.

Am J Transplant. 2015 May;15(5):1421-31. doi: 10.1111/ajt.13103. Epub 2015 Mar 16.

23.

Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis.

Zhang GL, Keskin DB, Lin HN, Lin HH, DeLuca DS, Leppanen S, Milford EL, Reinherz EL, Brusic V.

Front Immunol. 2014 Nov 27;5:597. doi: 10.3389/fimmu.2014.00597. eCollection 2014.

24.

Letter: the need for a definitive clinical trial of cryopreserved red blood cells.

Milford EM, Tung JP, Reade MC.

J Trauma Acute Care Surg. 2014 Dec;77(6):1004. doi: 10.1097/TA.0000000000000463. No abstract available.

PMID:
25423546
25.

The combined risk of donor quality and recipient age: higher-quality kidneys may not always improve patient and graft survival.

Hernandez RA, Malek SK, Milford EL, Finlayson SR, Tullius SG.

Transplantation. 2014 Nov 27;98(10):1069-76. doi: 10.1097/TP.0000000000000181.

26.

Donor chimerism early after reduced-intensity conditioning hematopoietic stem cell transplantation predicts relapse and survival.

Koreth J, Kim HT, Nikiforow S, Milford EL, Armand P, Cutler C, Glotzbecker B, Ho VT, Antin JH, Soiffer RJ, Ritz J, Alyea EP 3rd.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1516-21. doi: 10.1016/j.bbmt.2014.05.025. Epub 2014 Jun 4.

27.

An age-of-blood transfusion trial in the trauma setting is crucial and animal models may help inform trial design.

Milford EM, Reade MC, Shekar K, Tung JP, Fraser JF.

Crit Care Resusc. 2014 Jun;16(2):149-50. No abstract available.

PMID:
24888291
28.

Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.

Riella LV, Safa K, Yagan J, Lee B, Azzi J, Najafian N, Abdi R, Milford E, Mah H, Gabardi S, Malek S, Tullius SG, Magee C, Chandraker A.

Transplantation. 2014 Jun 27;97(12):1247-52. doi: 10.1097/01.TP.0000442782.98131.7c.

PMID:
24854670
29.

The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplant.

Chandraker A, Arscott R, Murphy GF, Lian CG, Bueno EM, Marty FM, Rennke HG, Milford E, Tullius SG, Pomahac B.

Am J Transplant. 2014 Jun;14(6):1446-52. doi: 10.1111/ajt.12715. Epub 2014 May 2.

30.

Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates.

Kim M, Townsend KR, Wood IG, Boukedes S, Guleria I, Gabardi S, El-Chemaly S, Camp PC, Chandraker AK, Milford EL, Goldberg HJ.

Am J Respir Crit Care Med. 2014 May 15;189(10):1234-9. doi: 10.1164/rccm.201312-2160OC.

PMID:
24749479
31.

TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.

Frischer JM, Reindl M, Künz B, Berger T, Schmidt S, Milford EL, Knosp E, Lassmann H, Utku N.

Mult Scler. 2014 Aug;20(9):1171-81. doi: 10.1177/1352458514521516. Epub 2014 Feb 13.

PMID:
24526664
32.

Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients.

Daly KP, Chandler SF, Almond CS, Singh TP, Mah H, Milford E, Matte GS, Bastardi HJ, Mayer JE, Fynn-Thompson F, Blume ED.

Pediatr Transplant. 2013 Nov;17(7):661-9. doi: 10.1111/petr.12131. Epub 2013 Aug 6.

33.

The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.

Lee BT, Kumar V, Williams TA, Abdi R, Bernhardy A, Dyer C, Conte S, Genovese G, Ross MD, Friedman DJ, Gaston R, Milford E, Pollak MR, Chandraker A.

Am J Transplant. 2012 Jul;12(7):1924-8. doi: 10.1111/j.1600-6143.2012.04033.x. Epub 2012 Apr 4.

34.

Impact of accidental discovery of renal cell carcinoma at time of renal transplantation on patient or graft survival.

Sheashaa HA, Rennke HG, Bakr MA, Abbas TM, Atta AF, Sangak A, Mah H, Milford E, Chandraker A.

Transplantation. 2011 Nov 27;92(10):1123-8. doi: 10.1097/TP.0b013e3182339cdd.

PMID:
21956203
35.

Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

Cutler C, Kim HT, Sun L, Sese D, Glotzbecker B, Armand P, Koreth J, Ho V, Alyea E, Ballen K, Ritz J, Soiffer RJ, Milford E, Antin JH.

Blood. 2011 Dec 15;118(25):6691-7. doi: 10.1182/blood-2011-05-355263. Epub 2011 Sep 22.

36.

Kidney allocation and the aging immune response.

Tullius SG, Milford E.

N Engl J Med. 2011 Apr 7;364(14):1369-70. doi: 10.1056/NEJMc1103007. Epub 2011 Mar 16. No abstract available.

PMID:
21410395
37.

Longitudinal trends and influence of BMI mismatch in living kidney donors and their recipients.

Lin J, McGovern ME, Brunelli SM, Gaccione P, Malek S, Tullius SG, Chandraker AK, Milford EL.

Int Urol Nephrol. 2011 Sep;43(3):891-7. doi: 10.1007/s11255-011-9921-1. Epub 2011 Mar 8.

38.

The National Marrow Donor Program: improving access to hematopoietic cell transplantation.

Walker T, Milford E, Chell J, Maiers M, Confer D.

Clin Transpl. 2011:55-62.

PMID:
22755401
39.

Racial and ethnic disparities in kidney transplantation.

Malek SK, Keys BJ, Kumar S, Milford E, Tullius SG.

Transpl Int. 2011 May;24(5):419-24. doi: 10.1111/j.1432-2277.2010.01205.x. Epub 2010 Dec 17. Review.

40.

The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome.

Tullius SG, Tran H, Guleria I, Malek SK, Tilney NL, Milford E.

Ann Surg. 2010 Oct;252(4):662-74. doi: 10.1097/SLA.0b013e3181f65c7d.

PMID:
20881773
41.

Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation.

Gabardi S, Waikar SS, Martin S, Roberts K, Chen J, Borgi L, Sheashaa H, Dyer C, Malek SK, Tullius SG, Vadivel N, Grafals M, Abdi R, Najafian N, Milford E, Chandraker A.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1298-304. doi: 10.2215/CJN.08261109. Epub 2010 May 27.

42.

Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.

McDermott DH, Conway SE, Wang T, Ricklefs SM, Agovi MA, Porcella SF, Tran HT, Milford E, Spellman S, Abdi R.

Blood. 2010 Mar 18;115(11):2311-8. doi: 10.1182/blood-2009-08-237768. Epub 2010 Jan 12.

43.

Factors associated with the recruitment and retention of dentists in the public sector.

Hopcraft MS, Milford E, Yapp K, Lim Y, Tan V, Goh L, Low CC, Phan T.

J Public Health Dent. 2010 Spring;70(2):131-9. doi: 10.1111/j.1752-7325.2009.00153.x.

PMID:
20002877
44.

A pilot study on the immunological effects of oral administration of donor major histocompatibility complex class II peptides in renal transplant recipients.

Womer KL, Magee CC, Najafian N, Vella JP, Milford EL, Sayegh MH, Carpenter CB.

Clin Transplant. 2008 Nov-Dec;22(6):754-9. doi: 10.1111/j.1399-0012.2008.00871.x. Epub 2008 Jul 18.

PMID:
18647327
45.

Dependence of antibody-mediated presentation of antigen on FcRn.

Qiao SW, Kobayashi K, Johansen FE, Sollid LM, Andersen JT, Milford E, Roopenian DC, Lencer WI, Blumberg RS.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9337-42. doi: 10.1073/pnas.0801717105. Epub 2008 Jul 1.

46.

Managing anemia in dialysis patients: hemoglobin cycling and overshoot.

Singh AK, Milford E, Fishbane S, Keithi-Reddy SR.

Kidney Int. 2008 Sep;74(5):679-83. doi: 10.1038/ki.2008.59. Epub 2008 Mar 12. No abstract available.

47.

HLA-DR alpha 2 mediates negative signalling via binding to Tirc7 leading to anti-inflammatory and apoptotic effects in lymphocytes in vitro and in vivo.

Bulwin GC, Wälter S, Schlawinsky M, Heinemann T, Schulze A, Höhne W, Krause G, Kalka-Moll W, Fraser P, Volk HD, Löhler J, Milford EL, Utku N.

PLoS One. 2008 Feb 13;3(2):e1576. doi: 10.1371/journal.pone.0001576.

48.

Role of beta3 integrin in acute renal allograft rejection in humans.

Chandrakantan A, McDermott DH, Tran HT, Jurewicz M, Gallon L, Gaston R, Milford E, Abdi R.

Clin J Am Soc Nephrol. 2007 Nov;2(6):1268-73. Epub 2007 Oct 10.

49.

T-cell immune response cDNA 7 in allograft rejection and inflammation.

Utku N, Heinemann T, Milford EL.

Curr Opin Investig Drugs. 2007 May;8(5):401-10. Review.

PMID:
17520869
50.

Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation.

Jurewicz M, McDermott DH, Sechler JM, Tinckam K, Takakura A, Carpenter CB, Milford E, Abdi R.

J Am Soc Nephrol. 2007 Apr;18(4):1093-102. Epub 2007 Feb 28.

Supplemental Content

Loading ...
Support Center